Neuroprotective potential of ketamine prevents developing brain structure impairment and alteration of neurocognitive function induced via isoflurane through the PI3K/AKT/GSK-3 beta pathway | |
Wang, Ruiwei; Zhang, Zihao; Kumar, Mukesh; Xu, Guangming; Zhang, Mengyuan | |
刊名 | DRUG DESIGN DEVELOPMENT AND THERAPY |
2019 | |
卷号 | 13页码:501-512 |
关键词 | ketamine isoflurane neuroinflammatory PI3K/AKT/GSK-3 beta pathway cognitive impairment |
DOI | 10.2147/DDDT.S188636 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4535846 |
专题 | 山东大学 |
作者单位 | 1.Shandong Univ, Shandong Prov Hosp, Dept Anesthesiol, 324 Jingwu Rd, Jinan 250021, Shandong, Peoples R China. 2.[Zhang |
推荐引用方式 GB/T 7714 | Wang, Ruiwei,Zhang, Zihao,Kumar, Mukesh,et al. Neuroprotective potential of ketamine prevents developing brain structure impairment and alteration of neurocognitive function induced via isoflurane through the PI3K/AKT/GSK-3 beta pathway[J]. DRUG DESIGN DEVELOPMENT AND THERAPY,2019,13:501-512. |
APA | Wang, Ruiwei,Zhang, Zihao,Kumar, Mukesh,Xu, Guangming,&Zhang, Mengyuan.(2019).Neuroprotective potential of ketamine prevents developing brain structure impairment and alteration of neurocognitive function induced via isoflurane through the PI3K/AKT/GSK-3 beta pathway.DRUG DESIGN DEVELOPMENT AND THERAPY,13,501-512. |
MLA | Wang, Ruiwei,et al."Neuroprotective potential of ketamine prevents developing brain structure impairment and alteration of neurocognitive function induced via isoflurane through the PI3K/AKT/GSK-3 beta pathway".DRUG DESIGN DEVELOPMENT AND THERAPY 13(2019):501-512. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论